| pubmed-article:10919162 | rdf:type | pubmed:Citation | lld:pubmed |
| pubmed-article:10919162 | lifeskim:mentions | umls-concept:C0030705 | lld:lifeskim |
| pubmed-article:10919162 | lifeskim:mentions | umls-concept:C0018213 | lld:lifeskim |
| pubmed-article:10919162 | lifeskim:mentions | umls-concept:C0040139 | lld:lifeskim |
| pubmed-article:10919162 | lifeskim:mentions | umls-concept:C0242485 | lld:lifeskim |
| pubmed-article:10919162 | lifeskim:mentions | umls-concept:C1510438 | lld:lifeskim |
| pubmed-article:10919162 | lifeskim:mentions | umls-concept:C0079411 | lld:lifeskim |
| pubmed-article:10919162 | pubmed:issue | 4 | lld:pubmed |
| pubmed-article:10919162 | pubmed:dateCreated | 2000-8-15 | lld:pubmed |
| pubmed-article:10919162 | pubmed:abstractText | The detection of TSH-receptor-antibodies (TRAb) in patients (pts) with Graves' disease (GD) is routinely used in nuclear medicine laboratories. It is performed by commercial, porcine radioreceptorassays (RRA) measuring TSH binding inhibitory activity. A second generation assay using the human, recombinant TSH-receptor was developed during the last years. The manufacturer composed this new assay as a coated tube RRA (CT RRA) and claimed a higher sensitivity for GD. | lld:pubmed |
| pubmed-article:10919162 | pubmed:language | ger | lld:pubmed |
| pubmed-article:10919162 | pubmed:journal | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:10919162 | pubmed:citationSubset | IM | lld:pubmed |
| pubmed-article:10919162 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:10919162 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:10919162 | pubmed:status | MEDLINE | lld:pubmed |
| pubmed-article:10919162 | pubmed:issn | 0029-5566 | lld:pubmed |
| pubmed-article:10919162 | pubmed:author | pubmed-author:KochRR | lld:pubmed |
| pubmed-article:10919162 | pubmed:author | pubmed-author:FrankeW GWG | lld:pubmed |
| pubmed-article:10919162 | pubmed:author | pubmed-author:WunderlichGG | lld:pubmed |
| pubmed-article:10919162 | pubmed:author | pubmed-author:ZöphelKK | lld:pubmed |
| pubmed-article:10919162 | pubmed:issnType | Print | lld:pubmed |
| pubmed-article:10919162 | pubmed:volume | 39 | lld:pubmed |
| pubmed-article:10919162 | pubmed:owner | NLM | lld:pubmed |
| pubmed-article:10919162 | pubmed:authorsComplete | Y | lld:pubmed |
| pubmed-article:10919162 | pubmed:pagination | 113-20 | lld:pubmed |
| pubmed-article:10919162 | pubmed:dateRevised | 2007-1-12 | lld:pubmed |
| pubmed-article:10919162 | pubmed:meshHeading | pubmed-meshheading:10919162... | lld:pubmed |
| pubmed-article:10919162 | pubmed:meshHeading | pubmed-meshheading:10919162... | lld:pubmed |
| pubmed-article:10919162 | pubmed:meshHeading | pubmed-meshheading:10919162... | lld:pubmed |
| pubmed-article:10919162 | pubmed:meshHeading | pubmed-meshheading:10919162... | lld:pubmed |
| pubmed-article:10919162 | pubmed:meshHeading | pubmed-meshheading:10919162... | lld:pubmed |
| pubmed-article:10919162 | pubmed:meshHeading | pubmed-meshheading:10919162... | lld:pubmed |
| pubmed-article:10919162 | pubmed:meshHeading | pubmed-meshheading:10919162... | lld:pubmed |
| pubmed-article:10919162 | pubmed:meshHeading | pubmed-meshheading:10919162... | lld:pubmed |
| pubmed-article:10919162 | pubmed:meshHeading | pubmed-meshheading:10919162... | lld:pubmed |
| pubmed-article:10919162 | pubmed:meshHeading | pubmed-meshheading:10919162... | lld:pubmed |
| pubmed-article:10919162 | pubmed:meshHeading | pubmed-meshheading:10919162... | lld:pubmed |
| pubmed-article:10919162 | pubmed:meshHeading | pubmed-meshheading:10919162... | lld:pubmed |
| pubmed-article:10919162 | pubmed:meshHeading | pubmed-meshheading:10919162... | lld:pubmed |
| pubmed-article:10919162 | pubmed:year | 2000 | lld:pubmed |
| pubmed-article:10919162 | pubmed:articleTitle | [Measurement of thyrotropin receptor antibodies (TRAK) with a second generation assay in patients with Graves' disease]. | lld:pubmed |
| pubmed-article:10919162 | pubmed:affiliation | Klinik und Poliklinik für Nuklearmedizin, Universitätsklinikum Carl Gustav Carus, Technischen Universität Dresden, Deutschland. kzophel@rcs.urz.tu-dresden.de | lld:pubmed |
| pubmed-article:10919162 | pubmed:publicationType | Journal Article | lld:pubmed |
| pubmed-article:10919162 | pubmed:publicationType | Comparative Study | lld:pubmed |
| pubmed-article:10919162 | pubmed:publicationType | English Abstract | lld:pubmed |
